Use of HBV RNA and hepatitis B core-related antigen to predict change in serological status and disease activity in CHB.

Ghany MG, King WC, Hinerman AS, Lok AS, Lisker-Melman M, Chung RT, Terrault N, Janssen HLA, Khalili M, Lee WM, Lau DTY, Cloherty GA, Sterling RK